FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2040371293> ?p ?o ?g. }

• W2040371293 endingPage "859" @default.
• W2040371293 startingPage "853" @default.
• W2040371293 abstract "Purpose To investigate the association in Japanese between posterior vitreous attachment and the pathologies of typical age-related macular degeneration (AMD) and polypoidal choroidal vasculopathy (PCV), 2 major forms of exudative AMD. Design Retrospective observational case series. Participants A total of 378 eyes from 302 subjects (132 with typical AMD, 126 with PCV, 120 controls) from the University of Tokyo Hospital. Methods Posterior vitreous detachment (PVD) and vitreomacular adhesion (VMA) were investigated by B-mode ultrasonography and spectral-domain optical coherence tomography (SD-OCT), respectively. The greatest linear dimension (GLD) of initial photodynamic therapy (PDT) in a subset of the patients (n=92) receiving PDT was also investigated. Main Outcome Measures Number of eyes with complete PVD and with VMA. The GLD of initial PDT. Results In typical AMD eyes, the frequency of complete PVD was significantly lower (63 [56.8%] of 111 eyes) than in the controls (52 [70.3%] of 74 eyes, risk ratio [RR] 0.76, P=0.021) and the frequency of VMA tended to be higher (14/115 [12.2%] in typical AMD eyes and 6/86 [7.0%] in the controls, RR 2.15, P=0.099). The frequency of complete PVD [77 [63.1%] of the 122 eyes] and VMA (9/108 [8.3%]) in PCV eyes was the same as the controls (RR 0.91, P=0.415 and RR 1.29, P=0.615). In patients with unilateral exudative AMD, the frequency of complete PVD was lower in typical AMD eyes than in fellow eyes (odds ratio [OR] 0.111, P=0.026) and VMA was observed in 7 (17.5%) and 3 (7.5%) typical AMD and fellow eyes, respectively (OR 2.33, P=0.34), whereas in PCV eyes, the frequency of complete PVD was higher (OR 8.00, P=0.045) and the frequency of VMA was the same as in the fellow eyes (OR 0.80, P=1.00). The GLD of the eyes without complete PVD or with VMA was significantly larger than that in the eyes with complete PVD in typical AMD eyes (P=0.042) and the same as that in the eyes with complete PVD in PCV eyes (P=0.67). Conclusions There is an association between posterior vitreous attachment and typical AMD. However, this association is not evident in PCV. Financial Disclosure(s) The author(s) have no proprietary or commercial interest in any materials discussed in this article. To investigate the association in Japanese between posterior vitreous attachment and the pathologies of typical age-related macular degeneration (AMD) and polypoidal choroidal vasculopathy (PCV), 2 major forms of exudative AMD. Retrospective observational case series. A total of 378 eyes from 302 subjects (132 with typical AMD, 126 with PCV, 120 controls) from the University of Tokyo Hospital. Posterior vitreous detachment (PVD) and vitreomacular adhesion (VMA) were investigated by B-mode ultrasonography and spectral-domain optical coherence tomography (SD-OCT), respectively. The greatest linear dimension (GLD) of initial photodynamic therapy (PDT) in a subset of the patients (n=92) receiving PDT was also investigated. Number of eyes with complete PVD and with VMA. The GLD of initial PDT. In typical AMD eyes, the frequency of complete PVD was significantly lower (63 [56.8%] of 111 eyes) than in the controls (52 [70.3%] of 74 eyes, risk ratio [RR] 0.76, P=0.021) and the frequency of VMA tended to be higher (14/115 [12.2%] in typical AMD eyes and 6/86 [7.0%] in the controls, RR 2.15, P=0.099). The frequency of complete PVD [77 [63.1%] of the 122 eyes] and VMA (9/108 [8.3%]) in PCV eyes was the same as the controls (RR 0.91, P=0.415 and RR 1.29, P=0.615). In patients with unilateral exudative AMD, the frequency of complete PVD was lower in typical AMD eyes than in fellow eyes (odds ratio [OR] 0.111, P=0.026) and VMA was observed in 7 (17.5%) and 3 (7.5%) typical AMD and fellow eyes, respectively (OR 2.33, P=0.34), whereas in PCV eyes, the frequency of complete PVD was higher (OR 8.00, P=0.045) and the frequency of VMA was the same as in the fellow eyes (OR 0.80, P=1.00). The GLD of the eyes without complete PVD or with VMA was significantly larger than that in the eyes with complete PVD in typical AMD eyes (P=0.042) and the same as that in the eyes with complete PVD in PCV eyes (P=0.67). There is an association between posterior vitreous attachment and typical AMD. However, this association is not evident in PCV." @default.
• W2040371293 created "2016-06-24" @default.
• W2040371293 creator A5030580390 @default.
• W2040371293 creator A5057381914 @default.
• W2040371293 creator A5060628794 @default.
• W2040371293 creator A5071947905 @default.
• W2040371293 creator A5076321370 @default.
• W2040371293 creator A5080762568 @default.
• W2040371293 creator A5080948472 @default.
• W2040371293 creator A5082046094 @default.
• W2040371293 date "2011-05-01" @default.
• W2040371293 modified "2023-09-30" @default.
• W2040371293 title "Vitreomacular Interface in Typical Exudative Age-related Macular Degeneration and Polypoidal Choroidal Vasculopathy" @default.
• W2040371293 cites W1498454320 @default.
• W2040371293 cites W1601975653 @default.
• W2040371293 cites W1789824814 @default.
• W2040371293 cites W1971979121 @default.
• W2040371293 cites W1975730266 @default.
• W2040371293 cites W2001170297 @default.
• W2040371293 cites W2023343217 @default.
• W2040371293 cites W2024848735 @default.
• W2040371293 cites W2032125357 @default.
• W2040371293 cites W2041647424 @default.
• W2040371293 cites W2042818357 @default.
• W2040371293 cites W2054180058 @default.
• W2040371293 cites W2080591818 @default.
• W2040371293 cites W2081233482 @default.
• W2040371293 cites W2085255605 @default.
• W2040371293 cites W2106178997 @default.
• W2040371293 cites W2115095003 @default.
• W2040371293 cites W2133316983 @default.
• W2040371293 cites W2139681916 @default.
• W2040371293 cites W2139795069 @default.
• W2040371293 cites W2155236757 @default.
• W2040371293 cites W2168912282 @default.
• W2040371293 cites W2333124567 @default.
• W2040371293 cites W275314022 @default.
• W2040371293 cites W3199981447 @default.
• W2040371293 cites W4242983430 @default.
• W2040371293 doi "https://doi.org/10.1016/j.ophtha.2010.09.001" @default.
• W2040371293 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21095010" @default.
• W2040371293 hasPublicationYear "2011" @default.
• W2040371293 type Work @default.
• W2040371293 sameAs 2040371293 @default.
• W2040371293 citedByCount "31" @default.
• W2040371293 countsByYear W20403712932012 @default.
• W2040371293 countsByYear W20403712932013 @default.
• W2040371293 countsByYear W20403712932014 @default.
• W2040371293 countsByYear W20403712932015 @default.
• W2040371293 countsByYear W20403712932017 @default.
• W2040371293 countsByYear W20403712932018 @default.
• W2040371293 countsByYear W20403712932021 @default.
• W2040371293 countsByYear W20403712932023 @default.
• W2040371293 crossrefType "journal-article" @default.
• W2040371293 hasAuthorship W2040371293A5030580390 @default.
• W2040371293 hasAuthorship W2040371293A5057381914 @default.
• W2040371293 hasAuthorship W2040371293A5060628794 @default.
• W2040371293 hasAuthorship W2040371293A5071947905 @default.
• W2040371293 hasAuthorship W2040371293A5076321370 @default.
• W2040371293 hasAuthorship W2040371293A5080762568 @default.
• W2040371293 hasAuthorship W2040371293A5080948472 @default.
• W2040371293 hasAuthorship W2040371293A5082046094 @default.
• W2040371293 hasConcept C118487528 @default.
• W2040371293 hasConcept C126322002 @default.
• W2040371293 hasConcept C141071460 @default.
• W2040371293 hasConcept C156957248 @default.
• W2040371293 hasConcept C167135981 @default.
• W2040371293 hasConcept C2776403814 @default.
• W2040371293 hasConcept C2779676219 @default.
• W2040371293 hasConcept C2780428090 @default.
• W2040371293 hasConcept C2780827179 @default.
• W2040371293 hasConcept C71924100 @default.
• W2040371293 hasConceptScore W2040371293C118487528 @default.
• W2040371293 hasConceptScore W2040371293C126322002 @default.
• W2040371293 hasConceptScore W2040371293C141071460 @default.
• W2040371293 hasConceptScore W2040371293C156957248 @default.
• W2040371293 hasConceptScore W2040371293C167135981 @default.
• W2040371293 hasConceptScore W2040371293C2776403814 @default.
• W2040371293 hasConceptScore W2040371293C2779676219 @default.
• W2040371293 hasConceptScore W2040371293C2780428090 @default.
• W2040371293 hasConceptScore W2040371293C2780827179 @default.
• W2040371293 hasConceptScore W2040371293C71924100 @default.
• W2040371293 hasFunder F4320320912 @default.
• W2040371293 hasIssue "5" @default.
• W2040371293 hasLocation W20403712931 @default.
• W2040371293 hasOpenAccess W2040371293 @default.
• W2040371293 hasPrimaryLocation W20403712931 @default.
• W2040371293 hasRelatedWork W1589365551 @default.
• W2040371293 hasRelatedWork W1969803413 @default.
• W2040371293 hasRelatedWork W2079353692 @default.
• W2040371293 hasRelatedWork W2139681916 @default.
• W2040371293 hasRelatedWork W2274897602 @default.
• W2040371293 hasRelatedWork W2992632417 @default.
• W2040371293 hasRelatedWork W4327593682 @default.
• W2040371293 hasRelatedWork W766991852 @default.
• W2040371293 hasRelatedWork W822914282 @default.
• W2040371293 hasRelatedWork W2398139548 @default.
• W2040371293 hasVolume "118" @default.

• next